Presentation TCT 2024 TCT 890: Transcatheter Aortic Valve Replacement in Low-Risk Patients at Four or More Years: A Meta-Analysis of Randomized Trials Presenter: John Connolly October 28, 2024
Presentation TCT 2024 TCT 141: Transcatheter Aortic-Valve Replacement (TAVR) Versus Surgical Aortic-Valve Replacement (SAVR) in Low-Risk Patients at Long Term Follow Up: Meta-Analysis of Randomized Controlled Trials Presenter: Sunny Goel October 27, 2024
Presentation TCT 2024 TCT 761: Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: A Systematic Review and Meta-Analysis Presenter: Prakash Upreti October 27, 2024
Presentation TCT 2024 TCT 146: Impact of Prosthesis-Patient Mismatch in Young and Low-Risk Patients After Newer Generation Balloon-Expandable Transcatheter Aortic Valve Replacement Presenter: Kazuki Suruga October 27, 2024
Presentation NY Valves 2024 Management of Aortic Stenosis in Low-Risk Patients – Current Options and Controversies Presenter: Vinod H. Thourani June 06, 2024
Presentation NY Valves 2024 A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial Presenter: Ole De Backer June 05, 2024
Presentation EuroPCR 2024 First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2 Presenter: Ole De Backer May 15, 2024
Presentation A Critical Assessment of Valve Performance and Outcomes in Patients at Low Risk for Surgery February 28, 2024
Presentation TCT 2023 TCT 444: Mid to Long-Term Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Severe Aortic Stenosis: A Systematic Review and Meta-Analysis Presenter: Muhammad Adil Afzal October 26, 2023
Presentation TCT 2023 Mitral Transcatheter Edge-to-Edge Repair in Intermediate and Low-Risk Patients: Rationale, Evidence, and Ongoing Studies Presenter: Gorav Ailawadi October 24, 2023
Presentation TCT 2020 TAVR in Low Surgical Risk Patients - Evidence Updates From Evolut Low-Risk Presenter: Michael Reardon October 16, 2020
Presentation TCT 2020 TCT 465: Implantation Characteristics and Development of Hypoattenuated Leaflet Thickening in Low Risk Patients undergoing Transcatheter Aortic Valve Replacement Presenter: Jaffar Khan October 14, 2020
Presentation TVT 2020 Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis Presenter: Bruce Rutkin June 20, 2020
Presentation Live Valves 2019 All AS Patients ( incl. Low-Risk) should be treated with TAVI Presenter: Christian W. Hamm December 10, 2019
Presentation TCT Abstracts Posters 2019 Transcatheter Aortic Valve Replacement in Low-risk Patients A Meta-analysis of Randomized Controlled Trials Presenter: Ahmad Al-Abdouh October 06, 2019
Presentation TCT Abstracts Posters 2019 Distribution of coronary artery disease in patients with low-risk transcatheter aortic valve replacement: A computed tomography coronary angiography study (from the LRT trial) Presenter: Yuichi Ozaki September 29, 2019
Presentation TCT 2019 TAVR in Low-Risk Patients: Strengths and Limitations of the Low-Risk Trials Presenter: Robert Bonow September 28, 2019
Presentation TCT 2019 Remaining Data Gaps After the Low-Risk TAVR RCTs Presenter: Michael Borger September 26, 2019
Presentation TCT 2019 Deep-Dive: NEW Insights From the Evolut Low-Risk Trial Presenter: Michael Reardon September 26, 2019